Get access to our best features
Get access to our best features
Published 1 month ago

Blackstone to invest up to $750 million in Moderna to develop new vaccines - The Boston Globe

Summary by Ground News
Moderna, one of the state’s largest biotechs, is trying to diversify its revenue stream after a global plunge in demand for COVID products last year. Moderna is working on several vaccines for other contagious diseases. It is also developing shots against cytomegalovirus, or CMV, a common infection caused by a type of herpes virus.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics